New Therapeutic Approaches in Diabetic Retinopathy. - Wikidata - awgldk - TriplyDB

New Therapeutic Approaches in Diabetic Retinopathy.

New Therapeutic Approaches in Diabetic Retinopathy.

http://www.wikidata.org/entity/Q33583037

about

Aloe-emodin suppresses hypoxia-induced retinal angiogenesis via inhibition of HIF-1α/VEGF pathway Formononetin, an active compound of Astragalus membranaceus (Fisch) Bunge, inhibits hypoxia-induced retinal neovascularization via the HIF-1α/VEGF signaling pathway Efficacy of intravitreal bevacizumab combined with pan retinal photocoagulation versus panretinal photocoagulation alone in treatment of proliferative diabetic retinopathy Inhibition of Hypoxia-Induced Retinal Angiogenesis by Specnuezhenide, an Effective Constituent of Ligustrum lucidum Ait., through Suppression of the HIF-1α/VEGF Signaling Pathway.Predictors of postoperative bleeding after vitrectomy for vitreous hemorrhage in patients with diabetic retinopathy.Histopathological and ophthalmoscopic evaluation of apocynin on experimental proliferative vitreoretinopathy in rabbit eyes.Functional changes in the neural retina occur in the absence of mitochondrial dysfunction in a rodent model of diabetic retinopathy.Engineering functional inorganic-organic hybrid systems: advances in siRNA therapeutics.

P2860

Q28820904-1CE83110-642D-41B7-A6B2-F9B3108294CA Q28828440-A876F0C2-D496-4425-9135-FA99D18B6718 Q36331321-0D4F542D-45CA-412A-91DC-459B062C1DDE Q38724669-4032DBD2-3878-4047-B478-C4DB4AB21022 Q47187973-31F42FF9-A902-469E-83C0-EC37BC6FC259 Q47401527-A065B414-697E-4A35-B831-512D499CCE08 Q47809831-46191481-5E72-43CB-A2F0-88E4BB02BE35 Q50123721-EF05AB89-711C-4ED8-8D84-76672280C8F2

P2860

New Therapeutic Approaches in Diabetic Retinopathy.

http://www.wikidata.org/entity/Q33583037

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

New Therapeutic Approaches in Diabetic Retinopathy.

@ast

New Therapeutic Approaches in Diabetic Retinopathy.

@en

New Therapeutic Approaches in Diabetic Retinopathy.

@nl

type

label

New Therapeutic Approaches in Diabetic Retinopathy.

@ast

New Therapeutic Approaches in Diabetic Retinopathy.

@en

New Therapeutic Approaches in Diabetic Retinopathy.

@nl

prefLabel

New Therapeutic Approaches in Diabetic Retinopathy.

@ast

New Therapeutic Approaches in Diabetic Retinopathy.

@en

New Therapeutic Approaches in Diabetic Retinopathy.

@nl

P1433

Q33583037-973951CF-850A-461D-8651-3BB50121D783

P1476

Q33583037-EE3CDDB5-7DDD-4E19-B124-73D2C6665C9F

P2093

Q33583037-0BA2E758-FCF7-4BBF-8DE1-E53B654611DA

Q33583037-1C201C22-AEC5-41B3-A684-A55A53376FE4

Q33583037-564A6B08-44C0-41AD-B41B-4BE3035D4F7F

Q33583037-57504315-BABF-4A73-B3F5-BC174BE5EEE3

Q33583037-B15D1CE8-8626-439E-A83D-CF83002B229E

P2860

Q33583037-0353711F-6ACF-4BA9-BB9A-D3ED90B9C4BD

Q33583037-041C1D03-2CB7-47FD-AEB7-0FA270F512FC

Q33583037-092093B1-91C5-40C0-A165-81E2C30510F2

Q33583037-0BC3DE4C-7911-42B5-9005-B897EA80EDCB

Q33583037-0F63A917-11AA-4D5E-AAD0-07DC88A6C4F5

Q33583037-13A9B12E-6594-4B5F-B1EC-7222D6C02993

Q33583037-15FAC922-06E9-42CA-9BCA-B0BDF6CBEEB2

Q33583037-16A44C40-BDA9-4D61-B9FB-8A7BE66D658D

Q33583037-192EE25A-B627-4EDE-8061-F2320A1A4C51

Q33583037-1E6DAB08-A3FE-4C27-AB9A-45A1535517D5

P304

Q33583037-D07B0F42-ACA2-4C77-882E-344318A1607B

P31

Q33583037-F53FA606-E617-4CCD-BE3B-F065B8940705

P356

Q33583037-4305AF8E-8D6C-4DD3-828A-38DF3E7EAD06

P433

Q33583037-A48BB148-7C7A-4562-A736-4D0FA68F5922

P478

Q33583037-F19ABDA8-60E5-44D7-A5D8-086EDEC012C1

P577

Q33583037-DD481D19-4B39-4A39-8CFE-D2F0BB99AABC

P698

Q33583037-9A43C995-7961-4D06-831A-E93178C70BE2

P932

Q33583037-E5220313-0A15-46CC-8176-07C6451F9BF7

P356

RDS.2015.12.196

P1433

The review of diabetic studies : RDS

P1476

New Therapeutic Approaches in Diabetic Retinopathy.

@en

P2093

Harry W Flynn

http://www.w3.org/2001/XMLSchema#string

Kamyar Vaziri

http://www.w3.org/2001/XMLSchema#string

Krishna S Kishor

http://www.w3.org/2001/XMLSchema#string

Nidhi Relhan

http://www.w3.org/2001/XMLSchema#string

Stephen G Schwartz

http://www.w3.org/2001/XMLSchema#string

P2860

Blood pressure control for diabetic retinopathy

Laser photocoagulation for proliferative diabetic retinopathy

Plasma kallikrein-kinin system and diabetic retinopathy

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Encapsulated cells for long-term secretion of soluble VEGF receptor 1: Material optimization and simulation of ocular drug response.

Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study).

The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study.

P304

196-210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1900/RDS.2015.12.196

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26676668

http://www.w3.org/2001/XMLSchema#string

P932

5397990

http://www.w3.org/2001/XMLSchema#string